Results 51 to 60 of about 647,081 (351)
Background Daily doses of pre-exposure prophylaxis (PrEP) can reduce the risk of acquiring HIV by more than 95 %. In sub-Saharan Africa, adolescent girls and young women (AGYW) are at disproportionately high risk of acquiring HIV, accounting for 25 % of ...
E. Rousseau +7 more
semanticscholar +1 more source
Barriers to PrEP uptake among Black female adolescents and emerging adults
Highlights • Pre-Exposure Prophylaxis (PrEP) is medication taken to prevent HIV.• Uptake of PrEP has been limited among Black adolescent girls and emerging adults.• Intersectional life experiences exacerbate Black AEA resistance to PrEP.• Medical ...
Natasha Crooks +8 more
semanticscholar +1 more source
This article explores the different ways in which gay men in Serbia perceive PrEP as a novel method of HIV prevention. In the article, I draw on data from my research on PrEP use among thirty gay men in Belgrade. The use of PrEP is still very low amongst
Zoran Milosavljević
doaj +1 more source
Summary Background PrEP was approved for HIV prevention in the US in 2012; uptake has been slow. We describe relative equity with the PrEP Equity Ratio (PER), a ratio of PrEP-to-Need Ratios (PnRs).
P. S. Sullivan +8 more
semanticscholar +1 more source
PURPOSE Adherence to pre-exposure prophylaxis (PrEP) during periods of PrEP-indication (i.e., prevention-effective adherence) is critical for preventing HIV.
Erin E. Cooney +17 more
semanticscholar +1 more source
Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors. [PDF]
IntroductionDeveloping guidelines to inform the use of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention in resource-limited settings must necessarily be informed by considering the resources and infrastructure needed for PrEP delivery ...
Brown, Marshall D +8 more
core +1 more source
HIV prevention clinical trials’ community engagement guidelines: inequality, and ethical conflicts
In 2004 and 2005, the first clinical trials were launched to investigate the use of tenofovir for HIV prevention in Cambodia, Cameroon, Nigeria and Thailand. Controversies erupted over the ethical integrity of the research protocol.
Morenike O. Folayan, Kristin Peterson
doaj +1 more source
HIV pre-exposure prophylaxis (PrEP) is an increasingly important part of the HIV prevention armamentarium. Issues with PrEP, however, include access. We propose that one way to surmount this issue would be to have nurses provide PrEP. Although clinical guidelines exist for PrEP, they are overwhelmingly not targeted to nonprescriber clinicians.
O'Byrne, Patrick +4 more
openaire +4 more sources
Trust in physicians among young sexual minority men [PDF]
Trust in physicians and the medical establishment more broadly is critical for access to and provision of relevant healthcare services. This is especially true for sexual minority men (SMM) as their healthcare is negatively impacted due to stigma and ...
Yifan Lai +6 more
doaj +1 more source
COVID-19 crisis effect on HIV service delivery in Egypt: Hard times or blessings in disguise?
No abstract available.
Rahma Mohamed +5 more
doaj +1 more source

